<?xml version="1.0" encoding="UTF-8"?>
<ref id="B97">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lanata</surname>
    <given-names>C. F.</given-names>
   </name>
   <name>
    <surname>Andrade</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Gil</surname>
    <given-names>A. I.</given-names>
   </name>
   <name>
    <surname>Terrones</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Valladolid</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Zambrano</surname>
    <given-names>B.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2012</year>). 
  <article-title>Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura.</article-title>
  <source>
   <italic>Peru. Vaccine</italic>
  </source>
  <volume>30</volume>
  <fpage>5935</fpage>â€“
  <lpage>5941</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2012.07.043</pub-id>
  <?supplied-pmid 22863660?>
  <pub-id pub-id-type="pmid">22863660</pub-id>
 </mixed-citation>
</ref>
